Extra support will propel Ultrahuman’s global growth plans as the waitlist for the app hits 100,000 users in just a few months.
Several tech investors and founders have come together to invest in Ultrahuman, a leading metabolic fitness platform that uses glucose biomarkers to help people optimise their lifestyle. Balaji Srinivasan (ex-Coinbase), Nithin Kamath (founder of Zerodha via Rainmatter) and Preethi Kasireddy (ex-a16z), along with several others, have made an undisclosed investment which will be in addition to their recent series A round.
Other influential leaders include Groww founders (Harsh Jain, Lalit Keshre, Neeraj Singh and Ishan Bansal), Razorpay founder, Harshil Mathur and RazorpayX GM – Shashank Mehta, Akshay BD (founding team Uber India) and Tanmay Bhat (celebrity content creator and investor).
Longevity.Technology: The metabolic health crisis is unarguably one of the largest healthcare crises that exist today – over a billion people in the world suffer from a metabolic health disorder which contributes to almost 85% of all chronic diseases in the world. By helping people understand how food and exercise affect their metabolic health, people would be able to make informed choices about what they eat and their activity levels.
Measuring a powerful biomarker like glucose can reveal a great deal about how a particular food item affects the user’s metabolic health. Glucose response is unique to an individual, and it depends on various factors like their gut microbiome, stress levels, time of the day, food ingredient quality, etc. Ultrahuman seeks to help people optimise their metabolism via real-time biomarkers like glucose in combination with HRV, sleep and activity insights.
Ultrahuman launched with Ultrahuman M1 – a metabolic health tracking platform that provides intelligent nudges based on glucose biomarkers and aims to improve users’ exercise, sleep and nutrition based on deep insights from the platform. The M1 tracks the wearer’s metabolism as they go about their day using a continuous glucose monitoring device. It triggers timely personalised prompts to the user such as alerts to high glucose variability events leading to oxidative stress and suggestions about lifestyle interventions.
Nithin Kamath, founder of Zerodha, said: “A big part of living healthier is tracking your diet and eating right, but the problem is doing this accurately is tricky. The approach that Ultrahuman is taking to tackle this problem of improving metabolic fitness by using biomarkers is really interesting. We’re excited to join Mohit and Vatsal on their journey.”
READ MORE: Ultrahuman snaps up LazyCo in the quest for better metabolic health
Ultrahuman has raised over $25m to date; existing investors include Alpha Wave, Steadview Capital, Nexus Venture Partners, Blume Ventures and Utsav Somani’s iSeed fund, and a range of other angel investors including Tiger Global’s Scott Schleifer.
“We’re super excited to welcome some of the world’s foremost founders, investors and biohackers to join our Series A round. The most inspiring aspect of this investment is that most of them are long term users of the platform as well and that strengthens our mission holistically,” said Mohit Kumar, Founder and CEO, Ultrahuman.
Ultrahuman was started by Mohit Kumar and Vatsal Singhal who were also co-founders at Runnr which later merged with India’s largest food delivery service Zomato. Kumar and Singhal are both avid biohackers, and Ultrahuman was born when Kumar observed athletes at one of the largest MMA Camps in the world (Tiger Muay Thai in Thailand) “smart training” using data, recovery tools and protocols. By using glucose and other biomarkers, Ultrahuman aims to help people improve their energy levels, increase focus and avoid metabolic disorders.
